We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$342M
AUM Growth
+$51.1M
(+18%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
13.91%
Top 10 Holdings %
Top 10 Hldgs %
10.44%
Holding
675
New
141
Increased
130
Reduced
57
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$4.02M |
| 2 |
Nike
NKE
|
+$3.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$3.69M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$3.63M |
| 5 |
Costco
COST
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$3.04M |
| 2 |
Visa
V
|
+$2.98M |
| 3 |
Procter & Gamble
PG
|
+$2.96M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$2.94M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$2.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.97% |
| 2 | Industrials | 12.49% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Staples | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTM
251
DELISTED
Tata Motors Limited
TTM
| $338K | 0.1% |
8,453
+7,000
| +482% | +$272K |
|
252
Adobe
ADBE
$105B
| $336K | 0.1% |
3,100
-800
| -21% | -$80.3K |
|
253
New Oriental
EDU
$9.15B
| $334K | 0.1% |
7,200
-300
| -4% | -$13K |
|
|
SRCI
254
DELISTED
SRC Energy Inc
SRCI
| $333K | 0.1% |
+48,100
| New | +$318K |
|
255
Genpact
G
$6.26B
| $328K | 0.1% |
+13,700
| New | +$339K |
|
|
CSRA
256
DELISTED
CSRA Inc.
CSRA
| $325K | 0.1% |
12,100
+6,000
| +98% | +$155K |
|
|
JOY
257
DELISTED
Joy Global Inc
JOY
| $325K | 0.1% |
11,699
+11,000
| +1,574% | +$292K |
|
|
IPG
258
DELISTED
Interpublic Group of Companies
IPG
| $324K | 0.09% |
+14,488
| New | +$333K |
|
259
Prudential Financial
PRU
$42.9B
| $323K | 0.09% |
+3,951
| New | +$303K |
|
260
Diamondback Energy
FANG
$55.8B
| $319K | 0.09% |
3,300
+2,000
| +154% | +$184K |
|
261
Allison Transmission
ALSN
$9.49B
| $314K | 0.09% |
10,936
+3,300
| +43% | +$93.1K |
|
262
Bank of Montreal
BMO
$124B
| $314K | 0.09% |
+4,789
| New | +$311K |
|
|
GRUB
263
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $314K | 0.09% |
+3,651
| New | +$274K |
|
264
Leidos
LDOS
$14.5B
| $312K | 0.09% |
+7,201
| New | +$327K |
|
265
Progressive
PGR
$128B
| $311K | 0.09% |
9,859
-9,600
| -49% | -$313K |
|
266
JetBlue
JBLU
$2.17B
| $303K | 0.09% |
17,576
+14,200
| +421% | +$243K |
|
267
Exelon
EXC
$48B
| $302K | 0.09% |
12,729
+140
| +1% | +$3.52K |
|
|
AZPN
268
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $299K | 0.09% |
+6,400
| New | +$299K |
|
|
SONC
269
DELISTED
Sonic Corp
SONC
| $298K | 0.09% |
+11,400
| New | +$314K |
|
|
FLIR
270
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $295K | 0.09% |
+9,400
| New | +$296K |
|
271
Entergy
ETR
$50.9B
| $292K | 0.09% |
7,600
-1,000
| -12% | -$39.8K |
|
272
TJX Companies
TJX
$179B
| $292K | 0.09% |
7,800
+2,000
| +34% | +$78.3K |
|
|
RSPP
273
DELISTED
RSP Permian, Inc.
RSPP
| $287K | 0.08% |
7,400
+1,200
| +19% | +$44.4K |
|
|
RAI
274
DELISTED
Reynolds American Inc
RAI
| $285K | 0.08% |
+6,046
| New | +$303K |
|
|
STRZA
275
DELISTED
Starz - Series A
STRZA
| $284K | 0.08% |
+9,100
| New | +$280K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Seven Eight Capital held 675 positions worth $342M, up 18% from $291M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $47.6M of net new capital in Q3 2016, opening 141 new positions and adding to 130 existing holdings. Its largest new stake was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Mastercard, an estimated $2.55M trimmed.
- Seven Eight Capital's largest Q3 2016 buy was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
- Seven Eight Capital added most to Bristol-Myers Squibb in Q3 2016, an estimated $3.69M increase.
- Seven Eight Capital's biggest Q3 2016 reduction was Mastercard, cutting an estimated $2.55M.
- Seven Eight Capital fully exited PNC Financial Services in Q3 2016, selling an estimated $3.04M.
- Seven Eight Capital's ten largest holdings make up 10% of its $342M portfolio in Q3 2016.
- Seven Eight Capital opened 141 new positions and closed 344 in Q3 2016.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $342M.
Based on Seven Eight Capital's 13F filing for Q3 2016, filed 14 Nov 2016.